QUICKLINKS AND VIEW OPITONS
Sanofi-Aventis had long rejected concerns over the Acomplia’s psychiatric side effects
Thursday, October 23, 2008 12:04 pm Email this article
"Sanofi-Aventis [the drug company that makes Acomplia] had long rejected concerns over [Acomplia's] psychiatric side- effects, but failed to win approval for it from the US Food & Drug Administration," according to the Financial Times.
"Warnings to patients on the drug's use have been strengthened several times since its launch in Europe in 2006."
"The company said it 'believes that Acomplia will remain an important therapeutic answer to a highly prevalent and increasing unmet medical need', and pledged to continue studies on its use for patients with diabetes and at risk of cardiovascular disease." Comment
Comment: That is what drug companies ALWAYS say
That is what drug companies always say about serious side effects.
The always say “we don’t think these side effects are related to the drug” or “we don’t think these deaths were related to the drug” or “we don’t think these side effects are a problem” or “we did not realize that these were related to the drug.”
Always. Always. Always.
They have to or they would be sued out of business.
So if there is a serious side effect that seems to be related to the drug, it is always safest to assume that this side effect is caused by the drug.
Jack A. Sanofi-aventis weight loss drug pulled by EU. Financial Times. 2008 Oct 23.
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2017 - Larry Hobbs - All Rights Reserved.